COMPLEX CARBOHYDRATES: STRUCTURE, FUNCTION, SYNTHESIS
复杂碳水化合物:结构、功能、合成
基本信息
- 批准号:3335439
- 负责人:
- 金额:$ 16.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1975
- 资助国家:美国
- 起止时间:1975-02-01 至 1995-01-31
- 项目状态:已结题
- 来源:
- 关键词:N glycosidase aminosugar antibody formation aorta carbohydrate biosynthesis carbohydrate structure castanospermine cross immunity dolichol enzyme inhibitors enzyme mechanism enzyme structure enzyme substrate glycolipids glycoprotein biosynthesis glycoprotein structure glycoproteins glycosyltransferase liposomes low density lipoprotein mannose membrane activity membrane proteins oligosaccharides protein purification protein structure function receptor serine swine tissue /cell culture vascular smooth muscle
项目摘要
Our long term goals are to understand the biosynthesis, regulation and
function of the carbohydrate portion of membrane glycoproteins. Since
N-linked and O-linked oligosaccharides are found as components of many
membrane receptors, such as those for low density lipoprotein, insulin and
acetylcholine, these studies have important implications in a variety of
disease conditions such as atherosclerosis and diabetes.
Our strategy to achieve these goals will involve a multifaceted approach.
We will purify from pig aorta several key enzymes that we think, and the
literature suggests, are likely to be regulatory enzymes in the
biosynthesis of N-linked oligosaccharides. After purification to
homogeneity, antibody will be made against the proteins and oligonucleotide
probes will be synthesized based on the amino-terminal or other peptide
sequences. These tools will enable us to determine the levels of these
enzymes and their mRNAs at various stages of growth or development, and in
normal animals or animals fed high cholesterol diets. If the proteins in
aortic smooth muscle cells cross react with the antibodies, levels of
enzymes will be studied in these cells treated with various inhibitors.
These studies will be correlated with effects of inhibitors on the
formation of lipid-linked oligosaccharides in cultured smooth muscle cells.
Another approach will be to use inhibitors of N-linked and O-linked
oligosaccharide biosynthesis to study formation and function. We have
several new inhibitors of processing of N-linked oligosaccharides that we
want to characterize since they have new inhibitory properties and will
provide important information about structure-inhibition relations. At
present there are no useful inhibitors of O-linked oligosaccharides or
glycosyl transferases. Thus, we will develop some rapid methods to look for
such inhibitors and will test a number of antibodies and other glycosides
that we have obtained from various sources.
Finally, we have compelling evidence for the presence of mannosyl-O-serine
linkages in several different animal cell lines grown in culture. We will
determine the optimum conditions for introducing labeled mannose into these
proteins and then do more detailed characterization to establish this
linkage. The protein(s) having the mannosyl-serine will be purified to
homogeneity so that we can prepare antibody and oligonucleotide probes in
order to establish the location and function of the protein. The
biosynthesis of the mannosyl-serine will be studied and the mannosyl donor
determined.
我们的长期目标是了解生物合成、调节和
膜糖蛋白的碳水化合物部分的功能。自.以来
N-键和O-键的低聚糖是许多
膜受体,如低密度脂蛋白、胰岛素和
乙酰胆碱,这些研究对多种疾病具有重要意义
疾病状况,如动脉粥样硬化和糖尿病。
我们实现这些目标的战略将涉及多方面的方法。
我们将从猪的主动脉中提纯我们认为的几种关键酶,以及
文献表明,很可能是体内的调节酶
N-连接低聚糖的生物合成。提纯后至
同源性,抗体将针对蛋白质和寡核苷酸
将根据氨基末端或其他多肽来合成探针
序列。这些工具将使我们能够确定这些
酶及其mRNAs在生长或发育的不同阶段以及在
正常动物或喂食高胆固醇饲料的动物。如果体内的蛋白质
主动脉平滑肌细胞与抗体发生交叉反应,水平
将在这些细胞中研究用各种抑制剂处理的酶。
这些研究将与抑制剂对血管紧张素转换酶的影响相关
培养的平滑肌细胞中脂联寡糖的形成。
另一种方法是使用N-键和O-键的抑制剂
低聚糖的生物合成研究形成和功能。我们有
几种新的N-连接低聚糖加工抑制剂
想要表征它们,因为它们具有新的抑制特性
提供有关结构-抑制关系的重要信息。在…
目前还没有有用的O-连接低聚糖或
糖基转移酶。因此,我们将开发一些快速方法来寻找
这样的抑制剂,并将测试一些抗体和其他糖苷
我们从各种渠道获得的信息。
最后,我们有令人信服的证据证明甘露醇-O-丝氨酸的存在
在培养中生长的几个不同的动物细胞系之间的联系。我们会
确定将标记甘露糖引入这些材料的最佳条件
蛋白质,然后做更详细的表征来确定
联动。含有甘露糖丝氨酸的蛋白质(S)将被提纯到
同质性,这样我们就可以在
以确定蛋白质的位置和功能。这个
甘露糖醇-丝氨酸的生物合成将被研究,甘露糖醇供体
下定决心。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alan D Elbein其他文献
Alan D Elbein的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alan D Elbein', 18)}}的其他基金
COMPLEX CARBOHYDRATES--STRUCTURE, FUNCTION, SYNTHESIS
复杂碳水化合物——结构、功能、合成
- 批准号:
2800531 - 财政年份:1998
- 资助金额:
$ 16.53万 - 项目类别:
D-ARABINOSE SYNTHESIS AS A TARGET SITE FOR CHEMOTHERAPY
D-阿拉伯糖合成作为化疗的靶点
- 批准号:
6170509 - 财政年份:1998
- 资助金额:
$ 16.53万 - 项目类别:
D-ARABINOSE SYNTHESIS AS A TARGET SITE FOR CHEMOTHERAPY
D-阿拉伯糖合成作为化疗的靶点
- 批准号:
2661146 - 财政年份:1998
- 资助金额:
$ 16.53万 - 项目类别:
D-ARABINOSE SYNTHESIS AS A TARGET SITE FOR CHEMOTHERAPY
D-阿拉伯糖合成作为化疗的靶点
- 批准号:
2887764 - 财政年份:1998
- 资助金额:
$ 16.53万 - 项目类别:
MOLECULAR MECHANISMS OF CELL MIGRATION THROUGH MATRIX
细胞通过基质迁移的分子机制
- 批准号:
2285758 - 财政年份:1994
- 资助金额:
$ 16.53万 - 项目类别:
MOLECULAR MECHANISMS OF CELL MIGRATION THROUGH MATRIX
细胞通过基质迁移的分子机制
- 批准号:
2285757 - 财政年份:1994
- 资助金额:
$ 16.53万 - 项目类别:
LIPID-LINKED SACCHARIDES IN GLYCOPROTEIN SYNTHESIS
糖蛋白合成中的脂联糖
- 批准号:
3227142 - 财政年份:1991
- 资助金额:
$ 16.53万 - 项目类别:
LIPID-LINKED SACCHARIDES IN GLYCOPROTEIN SYNTHESIS
糖蛋白合成中的脂联糖
- 批准号:
3227140 - 财政年份:1991
- 资助金额:
$ 16.53万 - 项目类别:
LIPID LINKED SACCHARIDES IN GLYCOPROTEIN SYNTHESIS
糖蛋白合成中的脂联糖
- 批准号:
2414771 - 财政年份:1991
- 资助金额:
$ 16.53万 - 项目类别:
LIPID LINKED SACCHARIDES IN GLYCOPROTEIN SYNTHESIS
糖蛋白合成中的脂联糖
- 批准号:
2701057 - 财政年份:1991
- 资助金额:
$ 16.53万 - 项目类别:
相似海外基金
Production of aminosugar-containing hetero-oligosaccharides modulating gut microflora that promotes health and longevity
生产含有氨基糖的杂低聚糖,调节肠道微生物群,促进健康和长寿
- 批准号:
24580179 - 财政年份:2012
- 资助金额:
$ 16.53万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Novel Ribostamycins and SAR Study of Ring III Aminosugar
新型核霉素及环III氨基糖的SAR研究
- 批准号:
7023762 - 财政年份:2004
- 资助金额:
$ 16.53万 - 项目类别:
Novel Ribostamycins and SAR Study of Ring III Aminosugar
新型核霉素及环III氨基糖的SAR研究
- 批准号:
6861100 - 财政年份:2004
- 资助金额:
$ 16.53万 - 项目类别:
Novel Ribostamycins and SAR Study of Ring III Aminosugar
新型核霉素和环III氨基糖的SAR研究
- 批准号:
7340550 - 财政年份:2004
- 资助金额:
$ 16.53万 - 项目类别:
Novel Ribostamycins and SAR Study of Ring III Aminosugar
新型核霉素和环III氨基糖的SAR研究
- 批准号:
7195772 - 财政年份:2004
- 资助金额:
$ 16.53万 - 项目类别:
Novel Ribostamycins and SAR Study of Ring III Aminosugar
新型核霉素及环III氨基糖的SAR研究
- 批准号:
6770744 - 财政年份:2004
- 资助金额:
$ 16.53万 - 项目类别:
STEREOSPECIFIC SYNTHESIS OF AMINOSUGAR ANTIBIOTICS
氨基糖抗生素的立体定向合成
- 批准号:
3288508 - 财政年份:1985
- 资助金额:
$ 16.53万 - 项目类别:
THE STEREOSPECIFIC SYNTHESIS OF AMINOSUGAR ANTIBIOTICS
氨基糖抗生素的立体定向合成
- 批准号:
3288516 - 财政年份:1985
- 资助金额:
$ 16.53万 - 项目类别:
THE STEREOSPECIFIC SYNTHESIS OF AMINOSUGAR ANTIBIOTICS
氨基糖抗生素的立体定向合成
- 批准号:
3288512 - 财政年份:1985
- 资助金额:
$ 16.53万 - 项目类别:
THE STEREOSPECIFIC SYNTHESIS OF AMINOSUGAR ANTIBIOTICS
氨基糖抗生素的立体定向合成
- 批准号:
3288513 - 财政年份:1985
- 资助金额:
$ 16.53万 - 项目类别:














{{item.name}}会员




